Monday, September 17, 2018

US Markets 15 Sep 18

US markets closed higher.
BDI and Harpex continue to go lower.
Dollar Index broke support.

Instruments that show buying interest (3) from Dealer/Intermediary (sell-side participants)
UT 

  • Nasdaq
Neutral 
  • None
DT 
  • None

Instruments that show selling interest at extreme (2) by Dealer/Intermediary (sell-side participants)

UT 

  • None
Neutral 
  • None
DT 
  • None

Note
(1) COT Index >= 90, Buying interest at extreme
(2) COT Index <= 10, Selling interest at extreme
(3) COT Index >= 70, rising COT Index, monitor for trend reversal
Down Trend and Up Trend is based on 50 Simple Moving Average





Dow
Daily UT, Weekly UT
Potential resistance around 
TLU11, 26,627, 26,976, 29,106
Potential support around 25,784, 25,649, 25,336, 24,481, 24,170

S&P
Daily UT, Weekly UT
Potential resistance around 2,983, 3,219
Potential support around 2,874, 2,863, 2,825, 2,814, 2,786, 2,748, 2,710, 2,593

Nasdaq
Daily 
UT, Weekly UT
Potential resistance around TLU7, 7,706, 8,428
Potential support around 7,516, 7,282, 7,134, 6,982, TLU6, 6,857, 6,346, 6,261

Russell
Daily UT, Weekly UT
Potential resistance around 1,743, 
TLU3, 
1,779
Potential support around 1,708, 1,683, 1,624, 1,609, 1,585, 1,543, 1,519


Key event to watch out  (SG Time)
17 Sep, Mon
  • Japan holiday
  • 1700 Europe CPI (YoY) (Aug) 
18 Sep, Tue
  • 0930 Australia RBA Meeting Minutes
19 Sep, Wed
  • 1100 Japan BoJ Monetary Policy Statement (YoY)
  • 1200 Japan BoJ Press Conference   
  • 1630 UK CPI (YoY) (Aug) 
  • 2030 UK Building Permits (Aug)
  • 2100 Europe ECB President Draghi Speaks
  • 2230 US Crude Oil Inventories
20 Sep, Thu
  • 1530 Switzerland SNB Interest Rate Decision 
  • 1530 Switzerland SNB Monetary Policy Assessment
  • 1630 UK Retail Sales (MoM) (Aug) 
  • 2030 US Philadelphia Fed Manufacturing Index (Sep)
  • 2200 US Existing Home Sales (Aug) 
21 Sep, Fri
  • 1530 German Manufacturing PMI (Sep)
  • 2030 Canada Core CPI (MoM) (Aug) 
  • 2030 Canada Core Retail Sales (MoM) (Jul) 

No comments:

Post a Comment